title: Is there a link between the use of etanercept and Henoch-Schönlein purpura? Comment on: Henoch-Schonlein purpura in a patient with the rheumatoid arthritis receiving etanercept (Eur J Dermatol 2010; 20: 521-2).
authors.forename: Se Jin
authors.initials: SJ
authors.lastname: Park
authors.forename: Ji Hong
authors.initials: JH
authors.lastname: Kim
authors.forename: Jae Il
authors.initials: JI
authors.lastname: Shin
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068800:Etanercept; D006801:Humans; D011695:IgA Vasculitis / Q000139:chemically induced* / Q000276:immunology; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000009:adverse effects*; D018124:Receptors, Tumor Necrosis Factor; D012217:Rheumatoid Factor / Q000097:blood
chemical_list: D018501:Antirheumatic Agents; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D012217:Rheumatoid Factor; D000068800:Etanercept